BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33813948)

  • 1. Choice of Intensive Lifestyle Change and/or Metformin after Shared Decision Making for Diabetes Prevention: Results from the Prediabetes Informed Decisions and Education (PRIDE) Study.
    Moin T; Martin JM; Mangione CM; Grotts J; Turk N; Norris KC; Tseng CH; Jeffers KS; Castellon-Lopez Y; Frosch DL; Duru OK
    Med Decis Making; 2021 Jul; 41(5):607-613. PubMed ID: 33813948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial.
    Moin T; Duru OK; Turk N; Chon JS; Frosch DL; Martin JM; Jeffers KS; Castellon-Lopez Y; Tseng CH; Norris K; Mangione CM
    J Gen Intern Med; 2019 Nov; 34(11):2652-2659. PubMed ID: 31471729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Shared Decision-making for Diabetes Prevention: 24- and 36-Month Results From the Prediabetes Informed Decision and Education (PRIDE) Trial.
    Duru OK; Mangione CM; Turk N; Chon J; Fu J; Cheng G; Cheng F; Moss A; Frosch D; Jeffers KS; Castellon-Lopez Y; Tseng CH; Maranon R; Norris KC; Moin T
    Diabetes Care; 2023 Dec; 46(12):2218-2222. PubMed ID: 37770039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of a shared decision making intervention for diabetes prevention for women with a history of gestational diabetes mellitus: The Gestational diabetes Risk Attenuation for New Diabetes (GRAND study).
    Madievsky R; Vu A; Cheng F; Chon J; Turk N; Krueger A; Krong J; Maranon R; Liu S; Han CS; Norris KC; Mangione C; Page J; Thomas S; Duru OK; Moin T
    Contemp Clin Trials; 2023 Jan; 124():107007. PubMed ID: 36384219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia.
    Alfayez OM; Alsallum AA; Aljabri AF; Almutairi FS; Al-Azzeh O; Almalki OS; Al Yami MS; Almohammed OA
    Front Public Health; 2022; 10():989072. PubMed ID: 36159298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study.
    Moin T; Li J; Duru OK; Ettner S; Turk N; Keckhafer A; Ho S; Mangione CM
    Ann Intern Med; 2015 Apr; 162(8):542-8. PubMed ID: 25894024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
    Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
    Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
    Perreault L; Pan Q; Mather KJ; Watson KE; Hamman RF; Kahn SE;
    Lancet; 2012 Jun; 379(9833):2243-51. PubMed ID: 22683134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium.
    Goldberg RB; Aroda VR; Bluemke DA; Barrett-Connor E; Budoff M; Crandall JP; Dabelea D; Horton ES; Mather KJ; Orchard TJ; Schade D; Watson K; Temprosa M;
    Circulation; 2017 Jul; 136(1):52-64. PubMed ID: 28476766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention.
    O'Brien MJ; Moran MR; Tang JW; Vargas MC; Talen M; Zimmermann LJ; Ackermann RT; Kandula NR
    Diabetes Educ; 2016 Dec; 42(6):667-677. PubMed ID: 27621093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case study.
    Al-Omar HA; Czech M; Quang Nam T; Gottwald-Hostalek U; Vesic N; Whitehouse J; Dawson M
    J Diabetes; 2024 May; 16(5):e13553. PubMed ID: 38664882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapeutic options for prediabetes.
    Rendell M
    Expert Opin Pharmacother; 2021 Jan; 22(1):45-54. PubMed ID: 32892663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Beliefs Associated With Metformin Use Among Insured Adults With Prediabetes.
    McEwen LN; Hurst TE; Joiner KL; Herman WH
    Diabetes Care; 2022 Oct; 45(10):2282-2288. PubMed ID: 35926099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin in Prevention of Type 2 Diabetes.
    Snehalatha C; Priscilla S; Nanditha A; Arun R; Satheesh K; Ramachandran A
    J Assoc Physicians India; 2018 Mar; 66(3):60-3. PubMed ID: 30341871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PREVENT-DM Comparative Effectiveness Trial of Lifestyle Intervention and Metformin.
    O'Brien MJ; Perez A; Scanlan AB; Alos VA; Whitaker RC; Foster GD; Ackermann RT; Ciolino JD; Homko C
    Am J Prev Med; 2017 Jun; 52(6):788-797. PubMed ID: 28237635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.
    Goldberg RB; Mather K
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2077-90. PubMed ID: 22895669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
    Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
    Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
    Guardado-Mendoza R; Salazar-López SS; Álvarez-Canales M; Farfán-Vázquez D; Martínez-López YE; Jiménez-Ceja LM; Suárez-Pérez EL; Angulo-Romero F; Evia-Viscarra ML; Montes de Oca-Loyola ML; Durán-Pérez EG; Folli F; Aguilar-García A
    Metabolism; 2020 Mar; 104():154054. PubMed ID: 31887309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Metformin Use for Type 2 Diabetes Prevention.
    Moin T; Schmittdiel JA; Flory JH; Yeh J; Karter AJ; Kruge LE; Schillinger D; Mangione CM; Herman WH; Walker EA
    Am J Prev Med; 2018 Oct; 55(4):565-574. PubMed ID: 30126667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.
    Roberts S; Barry E; Craig D; Airoldi M; Bevan G; Greenhalgh T
    BMJ Open; 2017 Nov; 7(11):e017184. PubMed ID: 29146638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.